metronidazole has been researched along with lactulose in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Crowe, PT; Lunn, PG; Marsh, MN; Neale, G; Northrop-Clewes, C; Sullivan, PB | 1 |
| Cummings, JH; Elia, M; Pomare, EW; Scheppach, W | 1 |
| Crossley, IR; Williams, R | 1 |
| Caspary, WF; Hönig, M; Lembcke, B | 1 |
| Brown, PJ; Cripps, PJ; Gruffydd-Jones, TJ; Muir, P | 1 |
| Castiglione, F; Cozzolino, A; Di Girolamo, E; Grassia, R; Manguso, F; Mazzacca, G; Rispo, A | 1 |
| Dear, KL; Elia, M; Hunter, JO | 1 |
| Berstad, A; Hausken, T; Morken, MH; Nysaeter, G; Strand, EA | 1 |
| Shaikh, OS; Sundaram, V | 1 |
| Abbas, Z; Abid, S; Hamid, S; Islam, M; Jafri, W; Mumtaz, K; Shah, HA | 1 |
| Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
| Bezerra Filho, H; de Morais, MB; Melli, LC; Mello, CS; Rodrigues, MS; Tahan, S | 1 |
| Kamath, PS; Kim, WR; Leise, MD; Poterucha, JJ | 1 |
| Barbaro, F; Campanale, M; Cesario, V; D'angelo, G; Di Rienzo, TA; Gasbarrini, A; Gigante, G; Ojetti, V; Pitocco, D; Scavone, G; Vitale, G | 1 |
| Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H | 1 |
| de Rooster, H; Devriendt, N; Paepe, D; Serrano, G | 1 |
5 review(s) available for metronidazole and lactulose
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Hepatic encephalopathy: pathophysiology and emerging therapies.
Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc | 2009 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Management of hepatic encephalopathy in the hospital.
Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Metronidazole; Neomycin; Protein Synthesis Inhibitors; Recurrence; Rifamycins; Rifaximin; Terminology as Topic | 2014 |
7 trial(s) available for metronidazole and lactulose
| Article | Year |
|---|---|
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Breath hydrogen excretion by healthy cats after oral administration of oxytetracycline and metronidazole.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Breath Tests; Cats; Female; Hydrogen; Intestinal Mucosa; Intestines; Lactulose; Metronidazole; Oxytetracycline; Xylulose | 1996 |
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Breath Tests; Ciprofloxacin; Colonic Diseases; Crohn Disease; Female; Glucose; Humans; Ileal Diseases; Lactulose; Male; Metronidazole; Middle Aged; Treatment Outcome | 2003 |
Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?
Topics: Adult; Anti-Infective Agents; Bacteria; Breath Tests; Calorimetry; Circadian Rhythm; Colon; Colony Count, Microbial; Dietary Fiber; Exhalation; Fermentation; Gases; Gastrointestinal Transit; Humans; Hydrogen; Irritable Bowel Syndrome; Lactulose; Metronidazole; Treatment Outcome | 2005 |
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
Topics: Anti-Infective Agents; Dipeptides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Glucose; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Lactulose; Length of Stay; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2011 |
Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum.
Topics: Anti-Infective Agents; Area Under Curve; Bacterial Infections; Breath Tests; Child; Humans; Hydrogen; Intestinal Diseases; Intestine, Small; Lactulose; Metronidazole; Poverty; Residence Characteristics; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts.
Topics: Animals; C-Reactive Protein; Diet; Dog Diseases; Dogs; Lactulose; Metronidazole; Portal System; Portasystemic Shunt, Transjugular Intrahepatic; Treatment Outcome; Vascular Malformations | 2022 |
9 other study(ies) available for metronidazole and lactulose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Persistent diarrhea and malnutrition--the impact of treatment on small bowel structure and permeability.
Topics: Anti-Bacterial Agents; Antifungal Agents; Blood Proteins; Body Weight; Cell Membrane Permeability; Child, Preschool; Chloramphenicol; Diarrhea, Infantile; Female; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Infant; Infant Food; Intestinal Mucosa; Intestine, Small; Lactulose; Macrolides; Male; Mannitol; Metronidazole; Nutrition Disorders; Polyenes; Tuberculin | 1992 |
The contribution of the large intestine to blood acetate in man.
Topics: Acetates; Aged; Aged, 80 and over; Colon; Fasting; Female; Fermentation; Humans; Ileostomy; Lactulose; Male; Metronidazole; Middle Aged | 1991 |
Different actions of neomychin and metronidazole on breath hydrogen (H2) exhalation.
Topics: Adult; Breath Tests; Female; Humans; Hydrogen; Intestines; Lactulose; Male; Metronidazole; Neomycin | 1980 |
Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection.
Topics: Abdominal Pain; Adolescent; Adult; Animals; Antiprotozoal Agents; Breath Tests; Female; Giardia lamblia; Giardiasis; Humans; Hydrogen; Intestines; Irritable Bowel Syndrome; Lactulose; Male; Metronidazole; Middle Aged | 2008 |
Methane intestinal production and poor metabolic control in type I diabetes complicated by autonomic neuropathy.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Breath Tests; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Fermentation; Gastric Emptying; Gastrointestinal Motility; Glycated Hemoglobin; Humans; Insulin; Intestine, Small; Lactulose; Male; Methane; Metronidazole; Middle Aged; Young Adult | 2014 |
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin | 2020 |